According to SSF guidelines, which treatments have insufficient evidence for their use in treating fatigue in Sjögren syndrome?

Updated: Mar 05, 2021
  • Author: Sriya K Ranatunga, MD, MPH; Chief Editor: Herbert S Diamond, MD  more...
  • Print
Answer

Insufficient evidence to issue a recommendation was found for the following therapeutic options for fatigue:

  • Interleukin-1 inhibition (anakinra)
  • Azathioprine
  • Mycophenolate
  • Zidovudine
  • Doxycycline
  • Lamivudine
  • Leflunomide
  • Abatacept
  • Belimumab
  • Epratuzumab

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!